|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 99.62 INR | +0.95% |
|
-1.66% | +10.16% |
| 05-30 | Alembic Pharmaceuticals Gets US FDA Final Nod for Sacubitril and Valsartan Tablets | MT |
| 05-13 | Alembic Limited Recommends Dividend for the Year Ended 31 March, 2024 | CI |
Alembic Limited has informed that Mr. R. M. Kapadia, Director of the company has resigned with effect from August 14, 2014.
| 1st Jan change | Capi. | |
|---|---|---|
| +10.16% | 304M | |
| -11.78% | 26.36B | |
| +3.75% | 25.9B | |
| +27.31% | 25.67B | |
| +19.88% | 24.19B | |
| +36.75% | 20.37B | |
| +10.32% | 20.63B | |
| -4.55% | 18.43B | |
| +3.23% | 16.74B | |
| +38.26% | 16.42B |
ALEMBIC LIMITED 